Can Patents Deter Innovation? The Anticommons in Biomedical Research
- 1 May 1998
- journal article
- review article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 280 (5364) , 698-701
- https://doi.org/10.1126/science.280.5364.698
Abstract
The "tragedy of the commons" metaphor helps explain why people overuse shared resources. However, the recent proliferation of intellectual property rights in biomedical research suggests a different tragedy, an "anticommons" in which people underuse scarce resources because too many owners can block each other. Privatization of biomedical research must be more carefully deployed to sustain both upstream research and downstream product development. Otherwise, more intellectual property rights may lead paradoxically to fewer useful products for improving human health.Keywords
This publication has 16 references indexed in Scilit:
- The Tragedy of the Anticommons: Property in the Transition from Marx to MarketsHarvard Law Review, 1998
- Public Research and Private Development: Patents and Technology Transfer in Government-Sponsored ResearchVirginia Law Review, 1996
- Contracting into Liability Rules: Intellectual Property Rights and Collective Rights OrganizationsCalifornia Law Review, 1996
- Advances in prospect theory: Cumulative representation of uncertaintyJournal of Risk and Uncertainty, 1992
- On the Complex Economics of Patent ScopeColumbia Law Review, 1990
- The effects of graduate training on reasoning: Formal discipline and thinking about everyday-life events.American Psychologist, 1988
- Property Rights, Progress, and the Aircraft Patent AgreementThe Journal of Law and Economics, 1988
- The Folk Theorem in Repeated Games with Discounting or with Incomplete InformationEconometrica, 1986
- The Comedy of the Commons: Custom, Commerce, and Inherently Public PropertyThe University of Chicago Law Review, 1986
- The Problem of Social CostThe Journal of Law and Economics, 1960